Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Finasteride is not expected to be effective for treating Acne vulgaris.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Early diagnosis and treatment are crucial for managing female hair loss effectively.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Spironolactone helps regrow hair in women with hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

DHT affects testicular development and regulates spermatogenesis in some fish.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

DHT, a testosterone byproduct, causes male pattern baldness.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.